Correlating cell line studies with tissue distribution of DPP4/TMPRSS2 and human biological samples may better define the viral tropism of MERS-CoV.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres.International journal of molecular sciences · 2024
   Article
2. The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections.Scientific reports · 2022
   Article
3. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections.Oxidative medicine and cellular longevity · 2022
   Review
4. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.Proceedings of the National Academy of Sciences of the United States of America · 2021
   Article
5. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.Journal of virology · 2016
   Article
6. The emergence of the Middle East respiratory syndrome coronavirus.Pathogens and disease · 2014
   Review
7. Reply to Leow.The Journal of infectious diseases · 2013
   Article
8. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus.Proceedings of the National Academy of Sciences of the United States of America · 2013
   Article

Corrections and comments

• Commented on by
  Reply to Leow.2013
• Comment on
  Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as